中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2014年
8期
940-943
,共4页
王焰斌%崔刚%王小雷%陈伟新%程毅坚%翟宇佳%杨建安
王燄斌%崔剛%王小雷%陳偉新%程毅堅%翟宇佳%楊建安
왕염빈%최강%왕소뢰%진위신%정의견%적우가%양건안
抗原,CD95%Fas配体蛋白质%胰蛋白酶抑制剂%细胞凋亡%心肺转流术%心脏瓣膜假体植入%后处理
抗原,CD95%Fas配體蛋白質%胰蛋白酶抑製劑%細胞凋亡%心肺轉流術%心髒瓣膜假體植入%後處理
항원,CD95%Fas배체단백질%이단백매억제제%세포조망%심폐전류술%심장판막가체식입%후처리
Antigens,CD95%Fas ligand protein%Trypsin inhibitors%Apoptosis%Cardiopulmonary bypass%Heart valve prosthesis implantation%Postconditioning
目的 评价Fas/FasL信号通路在乌司他丁后处理减轻CPB下心脏瓣膜置换术患者心肌细胞凋亡中的作用.方法 择期CPB下心脏瓣膜置换术患者40例,性别不限,年龄21~ 59岁,心功能和ASA分级Ⅱ或Ⅲ级.采用随机数字表法,将患者分为2组(n=20):对照组(C组)和乌司他丁后处理组(U组).U组于主动脉开放前5 min经主动脉根部灌注乌司他丁4 000~5 000 U·kg-1 ·min-1(剂量1万U/kg);C组给予等容量生理盐水.于升动脉开放后45 min时取右心耳心肌组织,检测Fas、Fas配体(FasL)、caspase-8、Bcl-2、Bax表达和细胞凋亡情况,并计算Bcl-2与Bax表达的比值(Bcl-2/Bax).结果 与C组比较,U组心肌组织Fas、FasL、caspase-8及Bax表达下调,心肌组织Bcl-2表达上调,Bcl-2/Bax升高,凋亡指数降低(P<0.05).结论 乌司他丁后处理通过抑制Fas/FasL信号通路减轻CPB下心脏瓣膜置换术患者心肌细胞凋亡.
目的 評價Fas/FasL信號通路在烏司他丁後處理減輕CPB下心髒瓣膜置換術患者心肌細胞凋亡中的作用.方法 擇期CPB下心髒瓣膜置換術患者40例,性彆不限,年齡21~ 59歲,心功能和ASA分級Ⅱ或Ⅲ級.採用隨機數字錶法,將患者分為2組(n=20):對照組(C組)和烏司他丁後處理組(U組).U組于主動脈開放前5 min經主動脈根部灌註烏司他丁4 000~5 000 U·kg-1 ·min-1(劑量1萬U/kg);C組給予等容量生理鹽水.于升動脈開放後45 min時取右心耳心肌組織,檢測Fas、Fas配體(FasL)、caspase-8、Bcl-2、Bax錶達和細胞凋亡情況,併計算Bcl-2與Bax錶達的比值(Bcl-2/Bax).結果 與C組比較,U組心肌組織Fas、FasL、caspase-8及Bax錶達下調,心肌組織Bcl-2錶達上調,Bcl-2/Bax升高,凋亡指數降低(P<0.05).結論 烏司他丁後處理通過抑製Fas/FasL信號通路減輕CPB下心髒瓣膜置換術患者心肌細胞凋亡.
목적 평개Fas/FasL신호통로재오사타정후처리감경CPB하심장판막치환술환자심기세포조망중적작용.방법 택기CPB하심장판막치환술환자40례,성별불한,년령21~ 59세,심공능화ASA분급Ⅱ혹Ⅲ급.채용수궤수자표법,장환자분위2조(n=20):대조조(C조)화오사타정후처리조(U조).U조우주동맥개방전5 min경주동맥근부관주오사타정4 000~5 000 U·kg-1 ·min-1(제량1만U/kg);C조급여등용량생리염수.우승동맥개방후45 min시취우심이심기조직,검측Fas、Fas배체(FasL)、caspase-8、Bcl-2、Bax표체화세포조망정황,병계산Bcl-2여Bax표체적비치(Bcl-2/Bax).결과 여C조비교,U조심기조직Fas、FasL、caspase-8급Bax표체하조,심기조직Bcl-2표체상조,Bcl-2/Bax승고,조망지수강저(P<0.05).결론 오사타정후처리통과억제Fas/FasL신호통로감경CPB하심장판막치환술환자심기세포조망.
Objective To evaluate the role of Fas/FasL signaling pathway in ulinastatin postconditioning-induced attenuation of apoptosis in the myocardial cells of patients undergoing cardiac valve replacement with cardiopulmonary bypass (CPB).Methods Forty patients of both sexes,aged 21-59 yr,of ASA physical status Ⅱ or Ⅲ (NYHA class Ⅱ or Ⅲ),scheduled for elective cardiac valve replacement with CPB,were randomly divided into 2 groups (n =20 each):control group (group C),and ulinastatin postconditioning group (group U).In group U,ulinastatin 10 000 U/kg was perfused via the aortic root at 4 000-5 000 U·kg-1 ·min-1 starting from 5 min before aortic unclamping.In group C,the equal volume of normal saline was infused instead of ulinastatin.Myocardial specimens were taken from the right auricle at 45 min after aortic unclamping for determination of Fas,Fas ligand (FasL),caspase-8,Bcl-2 and Bax expression and cell apoptosis.The ratio of Bcl-2 expression to/Bax expression (Bcl-2/Bax) and apoptotic index were calculated.Results Fas,FasL,caspase-8 and Bax expression and apoptotic index were significantly lower,and Bcl-2 expression and Bcl-2/Bax were higher in group U than in group C.Conclusion Ulinastatin postconditioning attenuates apoptosis in the myocardial cells through inhibiting Fas/FasL signaling pathway in the patients undergoing cardiac valve replacement with CPB.